757 related articles for article (PubMed ID: 29222404)
1. Lack of Parkin Anticipates the Phenotype and Affects Mitochondrial Morphology and mtDNA Levels in a Mouse Model of Parkinson's Disease.
Pinto M; Nissanka N; Moraes CT
J Neurosci; 2018 Jan; 38(4):1042-1053. PubMed ID: 29222404
[No Abstract] [Full Text] [Related]
2. Parkin deficiency accelerates consequences of mitochondrial DNA deletions and Parkinsonism.
Song L; McMackin M; Nguyen A; Cortopassi G
Neurobiol Dis; 2017 Apr; 100():30-38. PubMed ID: 28042097
[TBL] [Abstract][Full Text] [Related]
3. The Absence of Parkin Does Not Promote Dopamine or Mitochondrial Dysfunction in PolgA
Scott L; Karuppagounder SS; Neifert S; Kang BG; Wang H; Dawson VL; Dawson TM
J Neurosci; 2022 Dec; 42(49):9263-9277. PubMed ID: 36280265
[TBL] [Abstract][Full Text] [Related]
4. Loss of Parkin contributes to mitochondrial turnover and dopaminergic neuronal loss in aged mice.
Noda S; Sato S; Fukuda T; Tada N; Uchiyama Y; Tanaka K; Hattori N
Neurobiol Dis; 2020 Mar; 136():104717. PubMed ID: 31846738
[TBL] [Abstract][Full Text] [Related]
5. PARIS induced defects in mitochondrial biogenesis drive dopamine neuron loss under conditions of parkin or PINK1 deficiency.
Pirooznia SK; Yuan C; Khan MR; Karuppagounder SS; Wang L; Xiong Y; Kang SU; Lee Y; Dawson VL; Dawson TM
Mol Neurodegener; 2020 Mar; 15(1):17. PubMed ID: 32138754
[TBL] [Abstract][Full Text] [Related]
6. Parkin deficiency exacerbate ethanol-induced dopaminergic neurodegeneration by P38 pathway dependent inhibition of autophagy and mitochondrial function.
Hwang CJ; Kim YE; Son DJ; Park MH; Choi DY; Park PH; Hellström M; Han SB; Oh KW; Park EK; Hong JT
Redox Biol; 2017 Apr; 11():456-468. PubMed ID: 28086194
[TBL] [Abstract][Full Text] [Related]
7. Endogenous Parkin Preserves Dopaminergic Substantia Nigral Neurons following Mitochondrial DNA Mutagenic Stress.
Pickrell AM; Huang CH; Kennedy SR; Ordureau A; Sideris DP; Hoekstra JG; Harper JW; Youle RJ
Neuron; 2015 Jul; 87(2):371-81. PubMed ID: 26182419
[TBL] [Abstract][Full Text] [Related]
8. Parkin cooperates with GDNF/RET signaling to prevent dopaminergic neuron degeneration.
Meka DP; Müller-Rischart AK; Nidadavolu P; Mohammadi B; Motori E; Ponna SK; Aboutalebi H; Bassal M; Annamneedi A; Finckh B; Miesbauer M; Rotermund N; Lohr C; Tatzelt J; Winklhofer KF; Kramer ER
J Clin Invest; 2015 May; 125(5):1873-85. PubMed ID: 25822020
[TBL] [Abstract][Full Text] [Related]
9. Parkin functionally interacts with PGC-1α to preserve mitochondria and protect dopaminergic neurons.
Zheng L; Bernard-Marissal N; Moullan N; D'Amico D; Auwerx J; Moore DJ; Knott G; Aebischer P; Schneider BL
Hum Mol Genet; 2017 Feb; 26(3):582-598. PubMed ID: 28053050
[TBL] [Abstract][Full Text] [Related]
10. Sigma-1 receptor regulates mitophagy in dopaminergic neurons and contributes to dopaminergic protection.
Wang M; Wan C; He T; Han C; Zhu K; Waddington JL; Zhen X
Neuropharmacology; 2021 Sep; 196():108360. PubMed ID: 33122030
[TBL] [Abstract][Full Text] [Related]
11. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
12. Striatal dysfunctions associated with mitochondrial DNA damage in dopaminergic neurons in a mouse model of Parkinson's disease.
Pickrell AM; Pinto M; Hida A; Moraes CT
J Neurosci; 2011 Nov; 31(48):17649-58. PubMed ID: 22131425
[TBL] [Abstract][Full Text] [Related]
13. Phenotypic characterization of recessive gene knockout rat models of Parkinson's disease.
Dave KD; De Silva S; Sheth NP; Ramboz S; Beck MJ; Quang C; Switzer RC; Ahmad SO; Sunkin SM; Walker D; Cui X; Fisher DA; McCoy AM; Gamber K; Ding X; Goldberg MS; Benkovic SA; Haupt M; Baptista MA; Fiske BK; Sherer TB; Frasier MA
Neurobiol Dis; 2014 Oct; 70():190-203. PubMed ID: 24969022
[TBL] [Abstract][Full Text] [Related]
14. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].
Hattori N
Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506
[TBL] [Abstract][Full Text] [Related]
15. Mutant Twinkle increases dopaminergic neurodegeneration, mtDNA deletions and modulates Parkin expression.
Song L; Shan Y; Lloyd KC; Cortopassi GA
Hum Mol Genet; 2012 Dec; 21(23):5147-58. PubMed ID: 22949510
[TBL] [Abstract][Full Text] [Related]
16. Parkin and PINK1 mitigate STING-induced inflammation.
Sliter DA; Martinez J; Hao L; Chen X; Sun N; Fischer TD; Burman JL; Li Y; Zhang Z; Narendra DP; Cai H; Borsche M; Klein C; Youle RJ
Nature; 2018 Sep; 561(7722):258-262. PubMed ID: 30135585
[TBL] [Abstract][Full Text] [Related]
17. Progressive parkinsonism due to mitochondrial impairment: Lessons from the MitoPark mouse model.
Beckstead MJ; Howell RD
Exp Neurol; 2021 Jul; 341():113707. PubMed ID: 33753138
[TBL] [Abstract][Full Text] [Related]
18. Characterization of a Cul9-Parkin double knockout mouse model for Parkinson's disease.
Hollville E; Joers V; Nakamura A; Swahari V; Tansey MG; Moy SS; Deshmukh M
Sci Rep; 2020 Oct; 10(1):16886. PubMed ID: 33037272
[TBL] [Abstract][Full Text] [Related]
19. The STING pathway does not contribute to behavioural or mitochondrial phenotypes in Drosophila Pink1/parkin or mtDNA mutator models.
Lee JJ; Andreazza S; Whitworth AJ
Sci Rep; 2020 Feb; 10(1):2693. PubMed ID: 32060339
[TBL] [Abstract][Full Text] [Related]
20. Mitoapocynin Treatment Protects Against Neuroinflammation and Dopaminergic Neurodegeneration in a Preclinical Animal Model of Parkinson's Disease.
Ghosh A; Langley MR; Harischandra DS; Neal ML; Jin H; Anantharam V; Joseph J; Brenza T; Narasimhan B; Kanthasamy A; Kalyanaraman B; Kanthasamy AG
J Neuroimmune Pharmacol; 2016 Jun; 11(2):259-78. PubMed ID: 26838361
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
